• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Danaher Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement

    4/17/26 8:28:34 AM ET
    $DHR
    Industrial Machinery/Components
    Industrials
    Get the next $DHR alert in real time by email
    8-K
    DANAHER CORP /DE/ false 0000313616 0000313616 2026-04-16 2026-04-16 0000313616 us-gaap:CommonStockMember 2026-04-16 2026-04-16 0000313616 dhr:M0.200SeniorNotesDue20262Member 2026-04-16 2026-04-16 0000313616 dhr:M2.100SeniorNotesDue20261Member 2026-04-16 2026-04-16 0000313616 dhr:A1.2SeniorNotesDue2027Member 2026-04-16 2026-04-16 0000313616 dhr:A0.45SeniorNotesDue2028Member 2026-04-16 2026-04-16 0000313616 dhr:A2.5SeniorNotesDue2030Member 2026-04-16 2026-04-16 0000313616 dhr:A0.75SeniorNotesDue2031Member 2026-04-16 2026-04-16 0000313616 dhr:A1.35SeniorNotesDue2039Member 2026-04-16 2026-04-16 0000313616 dhr:A1.8SeniorNotesDue2049Member 2026-04-16 2026-04-16
     
     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM 8-K

     

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d)

    of the Securities Exchange Act of 1934

    Date of report (Date of earliest event reported): April 16, 2026

     

     

     

    LOGO

    DANAHER CORPORATION

    (Exact Name of Registrant as Specified in Its Charter)

     

     

     

    Delaware   001-08089   59-1995548
    (State or Other Jurisdiction
    of Incorporation)
     

    (Commission

    File Number)

      (IRS Employer
    Identification No.)

     

    2200 Pennsylvania Avenue, NW   20037-1701
    Suite 800W
    Washington, DC
    (Address of Principal Executive Offices)   (Zip Code)

    202-828-0850

    (Registrant’s Telephone Number, Including Area Code)

    Not applicable

    (Former Name or Former Address, if Changed Since Last Report)

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

     

    ☐

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class

     

    Trading
    Symbol(s)

     

    Name of each exchange

    on which registered

    Common stock, $0.01 par value   DHR   New York Stock Exchange
    0.200% Senior Notes due 2026   DHR/26   New York Stock Exchange
    2.100% Senior Notes due 2026   DHR 26   New York Stock Exchange
    1.200% Senior Notes due 2027   DHR/27   New York Stock Exchange
    0.450% Senior Notes due 2028   DHR/28   New York Stock Exchange
    2.500% Senior Notes due 2030   DHR 30   New York Stock Exchange
    0.750% Senior Notes due 2031   DHR/31   New York Stock Exchange
    1.350% Senior Notes due 2039   DHR/39   New York Stock Exchange
    1.800% Senior Notes due 2049   DHR/49   New York Stock Exchange

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     
     


    ITEM 1.01

    ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT

    364-Day Revolving Credit Facility

    On April 16, 2026, Danaher Corporation (“Danaher”) entered into a new $5.0 billion 364-day revolving credit facility (the “Credit Facility”) with Bank of America, N.A., as Administrative Agent, and a syndicate of lenders from time to time party thereto. The Credit Facility expires on April 15, 2027 (the “Scheduled Termination Date”). Danaher may elect, upon the payment of a fee equal to 0.50% of the principal amount of the loans then outstanding and upon the satisfaction of certain conditions, to convert any loans outstanding on the Scheduled Termination Date into term loans that are due and payable one year following the Scheduled Termination Date. The description of the Credit Agreement with respect to the Credit Facility (the “Credit Agreement”) set forth herein is qualified in its entirety by reference to the full text of the Credit Agreement, a copy of which is attached as Exhibit 10.1 hereto and is incorporated by reference herein.

    Borrowings under the Credit Facility bear interest as follows: (i) Term SOFR Loans (as defined in the Credit Agreement) bear interest at a variable rate equal to the Term SOFR (as defined in the Credit Agreement) plus a margin of between 58.5 and 108.5 basis points, depending on Danaher’s long-term debt credit rating; and (ii) Base Rate Loans (as defined in the Credit Agreement) bear interest at a variable rate equal to the highest of (a) the Federal funds rate (as published by the Federal Reserve Bank of New York from time to time) plus 1/2 of 1%, (b) Bank of America’s “prime rate” as publicly announced from time to time, (c) Term SOFR (based on one-month interest period plus 1%) and (d) 1.0%, plus in each case a margin of between 0 to 8.5 basis points depending on Danaher’s long-term debt credit rating. In addition, Danaher is required to pay a per annum facility fee of 4.0 basis points based on the aggregate commitments under the Credit Facility, regardless of usage.

    The Credit Facility requires Danaher to maintain a Consolidated Leverage Ratio (as defined in the Credit Agreement) of 0.65 to 1.00 or less. Borrowings under the Credit Facility are prepayable at Danaher’s option at any time in whole or in part without premium or penalty.

    Danaher’s obligations under the Credit Facility are unsecured. Danaher has unconditionally and irrevocably guaranteed the obligations of each of its subsidiaries in the event a subsidiary is named a borrower under the Credit Facility. The Credit Agreement contains customary representations, warranties, conditions precedent, events of default, indemnities and affirmative and negative covenants, including covenants that, among other things, restrict the ability of Danaher and certain of its subsidiaries to: incur liens; sell or otherwise dispose of all or substantially all of Danaher’s or any subsidiary borrower’s assets; enter into certain mergers or consolidations; and use proceeds of borrowings under the Credit Facility for other than permitted uses. These covenants are subject to a number of important exceptions and qualifications. Certain changes of control with respect to Danaher would constitute an event of default under the Credit Facility. Upon the occurrence and during the continuance of an event of default, the lenders may declare the outstanding advances and all other obligations under the Credit Agreement immediately due and payable.

    Danaher intends to use the Credit Facility for liquidity support for Danaher’s U.S. dollar-denominated commercial paper program and for general corporate purposes.

     

    ITEM 2.03

    CREATION OF A DIRECT FINANCIAL OBLIGATION OR AN OBLIGATION UNDER AN OFF-BALANCE SHEET ARRANGEMENT OF A REGISTRANT

    The information set forth under Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference.

     


    ITEM 9.01

    FINANCIAL STATEMENTS AND EXHIBITS

    (c) Exhibits:

     

    Exhibit No.

      

    Description

    10.1    Credit Agreement, dated as of April 16, 2026, among Danaher Corporation, certain of its subsidiaries party thereto, Bank of America, N.A., as Administrative Agent, and the lenders referred to therein.
    104    Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101)

     


    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

        DANAHER CORPORATION
    Date: April 17, 2026     By:  

    /s/ James F. O’Reilly

         

    Name: James F. O’Reilly

    Title: Senior Vice President, Secretary and Deputy General Counsel

    Get the next $DHR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DHR

    DatePrice TargetRatingAnalyst
    6/3/2026$210.00Buy
    DZ Bank
    6/2/2026Peer Perform
    Wolfe Research
    5/26/2026$230.00Buy
    Citigroup
    5/15/2026$200.00Outperform
    RBC Capital Mkts
    12/9/2025$265.00Buy
    Goldman
    12/2/2025$270.00Overweight
    Morgan Stanley
    10/8/2025$220.00Buy → Neutral
    Rothschild & Co Redburn
    7/11/2025$275.00Sector Perform → Sector Outperform
    Scotiabank
    More analyst ratings

    $DHR
    SEC Filings

    View All

    Danaher Corporation filed SEC Form 8-K: Other Events

    8-K - DANAHER CORP /DE/ (0000313616) (Filer)

    6/3/26 4:30:18 PM ET
    $DHR
    Industrial Machinery/Components
    Industrials

    SEC Form SD filed by Danaher Corporation

    SD - DANAHER CORP /DE/ (0000313616) (Filer)

    5/12/26 4:31:13 PM ET
    $DHR
    Industrial Machinery/Components
    Industrials

    Danaher Corporation filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

    8-K - DANAHER CORP /DE/ (0000313616) (Filer)

    5/7/26 4:36:15 PM ET
    $DHR
    Industrial Machinery/Components
    Industrials

    $DHR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    DZ Bank initiated coverage on Danaher with a new price target

    DZ Bank initiated coverage of Danaher with a rating of Buy and set a new price target of $210.00

    6/3/26 8:10:49 AM ET
    $DHR
    Industrial Machinery/Components
    Industrials

    Wolfe Research resumed coverage on Danaher

    Wolfe Research resumed coverage of Danaher with a rating of Peer Perform

    6/2/26 8:32:53 AM ET
    $DHR
    Industrial Machinery/Components
    Industrials

    Citigroup resumed coverage on Danaher with a new price target

    Citigroup resumed coverage of Danaher with a rating of Buy and set a new price target of $230.00

    5/26/26 11:40:17 AM ET
    $DHR
    Industrial Machinery/Components
    Industrials

    $DHR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    SCIEX Launches the novus V55 System With SCIEX OS 5.0 Software and AI Enablement Tools

    At ASMS, SCIEX, a Danaher company and leader in life science analytical technologies, launched the novus V55 system - a next-generation triple quadrupole mass spectrometer designed for the realities of high-pressure, results-driven labs. The system provides exceptional sensitivity and accelerated output, in a smaller footprint and with improved energy efficiency when compared to the SCIEX 5500+ system. This quantitative solution expands testing capabilities across pesticide and food analysis, pharmaceutical impurities, bioanalysis, PFAS testing and additional applications. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260601916

    6/1/26 2:00:00 PM ET
    $DHR
    Industrial Machinery/Components
    Industrials

    SCIEX Advances the ZenoTOF Line With Platform-Wide Expansions in Software, Integrations, and Key Collaborations

    At ASMS, SCIEX, a Danaher company and leader in life science analytical technologies, introduced platform-wide advancements across its accurate mass ZenoTOF line. The updates include new SCIEX OS 5.0 software features, broader front-end compatibility, and forward-looking software collaborations designed to help omics researchers solve complex biological questions. This connected environment reduces workflow complexity, while enabling deeper, more actionable insights from a single, dynamic platform. SCIEX OS 5.0 software introduces new features including Central Metrics Tracker, Central Monitoring, Reporter Template Creator, an AI enabled "helpme" function, and AI enabled Calculated Column

    6/1/26 2:00:00 PM ET
    $DHR
    Industrial Machinery/Components
    Industrials

    Henry Schein Announces the Election of William K. "Dan" Daniel as Independent Chairman of the Board

    Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today announced that its Board of Directors has elected William K. "Dan" Daniel as Independent Chairman of the Board, effective May 21, 2026. Mr. Daniel succeeds Stanley M. Bergman, who retired from the Board following 44 years as a Director of Henry Schein and was named Chairman Emeritus in recognition of his extraordinary contributions to the Company. Mr. Daniel joined the Henry Schein Board of Directors in May 2025. He possesses decades of board and global executive leadership experience in healthcare and industrial sectors, including serving for 14

    5/22/26 8:00:00 AM ET
    $DHR
    $HSIC
    $NVST
    Industrial Machinery/Components
    Industrials
    Medical Specialities
    Health Care

    $DHR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP, Human Resources Couchara Georgeann covered exercise/tax liability with 281 shares, decreasing direct ownership by 3% to 8,291 units (SEC Form 4)

    4 - DANAHER CORP /DE/ (0000313616) (Issuer)

    5/19/26 5:10:04 PM ET
    $DHR
    Industrial Machinery/Components
    Industrials

    Director Filler Linda was granted 680 shares, increasing direct ownership by 3% to 24,712 units (SEC Form 4)

    4 - DANAHER CORP /DE/ (0000313616) (Issuer)

    5/19/26 5:10:11 PM ET
    $DHR
    Industrial Machinery/Components
    Industrials

    Director Stevens Raymond C was granted 680 shares, increasing direct ownership by 5% to 13,728 units (SEC Form 4)

    4 - DANAHER CORP /DE/ (0000313616) (Issuer)

    5/19/26 5:09:58 PM ET
    $DHR
    Industrial Machinery/Components
    Industrials

    $DHR
    Financials

    Live finance-specific insights

    View All

    Danaher Announces Quarterly Dividend

    WASHINGTON, May 5, 2026 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.40 per share of its common stock, payable on July 31, 2026 to holders of record on June 26, 2026. ABOUT DANAHERDanaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. Through our connected ecosystem of industry-leading businesses, we work side by side with customers to solve many of their most complex scientific and clinical challenges—helping move innovations from discovery to delivery faster for patients who depend on them.Pow

    5/5/26 4:30:00 PM ET
    $DHR
    Industrial Machinery/Components
    Industrials

    Danaher Reports First Quarter 2026 Results

    WASHINGTON, April 21, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) today announced results for the first quarter 2026.  All results in this release reflect only continuing operations and period-to-period comparisons are year-over-year unless otherwise noted. Key First Quarter 2026 ResultsNet earnings were $1.0 billion, or $1.45 per diluted common share.Non-GAAP adjusted diluted net earnings per common share grew 9.5% to $2.06.Revenues increased 3.5% year-over-year to $6.0 billion and non-GAAP core revenue increased 0.5% year-over-year.Operating cash flow was $1.3 billion and non-GAAP free cash flow was $1.1 billion.Strong Q1 earnings performance enabling increased full year 2026 adju

    4/21/26 6:00:00 AM ET
    $DHR
    Industrial Machinery/Components
    Industrials

    Danaher Schedules First Quarter 2026 Earnings Conference Call

    WASHINGTON, March 20, 2026 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) announced that it will webcast its quarterly earnings conference call for the first quarter 2026 on Tuesday, April 21, 2026 beginning at 8:00 a.m. ET and lasting approximately one hour. During the call, the company will discuss its financial performance, as well as future expectations. The call and an accompanying slide presentation will be webcast on the "Investors" section of Danaher's website, www.danaher.com, under the subheading "Events & Presentations." A replay of the webcast will be available shortly after the conclusion of the presentation and will remain available until the next quarterly earnings call.You ca

    3/20/26 4:15:00 PM ET
    $DHR
    Industrial Machinery/Components
    Industrials

    $DHR
    Leadership Updates

    Live Leadership Updates

    View All

    Danaher To Acquire Masimo Corporation

    WASHINGTON, Feb. 17, 2026 /PRNewswire/ -- Danaher Corporation (NYSE:DHR), a global science and technology innovator, announced today that it has entered into a definitive agreement to acquire Masimo Corporation (NASDAQ:MASI) a leading specialty diagnostics provider of pulse oximetry and other patient monitoring solutions, primarily in acute care settings. Under the terms of the agreement, Danaher will acquire all of the outstanding shares of Masimo common stock for $180 per share in cash, or a total enterprise value of approximately $9.9 billion including assumed indebtedness and net of acquired cash. This represents a transaction multiple of approximately 18x estimated 2027 EBITDA, or 15x 2

    2/17/26 8:00:00 AM ET
    $DHR
    $MASI
    Industrial Machinery/Components
    Industrials
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    AstroNova Appoints Jorik E. Ittmann as President and Chief Executive Officer

    Leverages Mr. Ittmann's extensive print industry and international business experience Padraig Finn, with over 16 years in the print industry, promoted to Senior Vice President, Product Identification Tom Carll, Senior Vice President, Aerospace, Thomas DeByle, CFO, and Michael Natalizia, Chief Technology Officer, round out the Executive Leadership Team Darius G. Nevin appointed Executive Chairman AstroNova, Inc. (NASDAQ:ALOT), a leading innovator in specialized print technology solutions that enable data visualization, today announced that the Board of Directors has promoted Jorik E. Ittmann to President and CEO and appointed him to the Board of Directors, both to be effective

    8/4/25 9:00:00 AM ET
    $ALOT
    $DHR
    $VLTO
    Computer peripheral equipment
    Technology
    Industrial Machinery/Components
    Industrials

    Danaher Appoints Jonathan Leiken as General Counsel

    WASHINGTON, July 31, 2025 /PRNewswire/ -- Danaher Corporation (NYSE:DHR), a leading global life sciences and diagnostics innovator, today announced that Jonathan Leiken has been appointed Senior Vice President and General Counsel, effective August 25, 2025. Mr. Leiken will report directly to President and Chief Executive Officer Rainer Blair and will serve as an executive officer and a member of the Danaher Leadership Team. Jonathan Leiken succeeds Brian Ellis, who will retire after nearly a decade of distinguished service as Danaher's General Counsel. Mr. Ellis will remain at Danaher in an executive officer role through February 2026 to support the transition. "Jon brings nearly three deca

    7/31/25 4:15:00 PM ET
    $DHR
    Industrial Machinery/Components
    Industrials

    $DHR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Danaher Corporation (Amendment)

    SC 13G/A - DANAHER CORP /DE/ (0000313616) (Subject)

    2/9/23 11:16:32 AM ET
    $DHR
    Industrial Machinery/Components
    Industrials

    SEC Form SC 13G/A filed by Danaher Corporation (Amendment)

    SC 13G/A - DANAHER CORP /DE/ (0000313616) (Subject)

    2/9/22 3:43:35 PM ET
    $DHR
    Industrial Machinery/Components
    Industrials

    SEC Form SC 13D/A filed by Danaher Corporation (Amendment)

    SC 13D/A - DANAHER CORP /DE/ (0000313616) (Subject)

    11/2/21 9:29:29 AM ET
    $DHR
    Industrial Machinery/Components
    Industrials